Literature DB >> 21213104

Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.

Junyi Jiang1, Hong Tang.   

Abstract

Hepatitis B virus (HBV) is regarded as a stealth virus, invading and replicating efficiently in human liver undetected by host innate antiviral immunity. Here, we show that type I interferon (IFN) induction but not its downstream signaling is blocked by HBV replication in HepG2.2.15 cells. This effect may be partially due to HBV X protein (HBx), which impairs IFNβ promoter activation by both Sendai virus (SeV) and components implicated in signaling by viral sensors. As a deubiquitinating enzyme (DUB), HBx cleaves Lys63-linked polyubiquitin chains from many proteins except TANK-binding kinase 1 (TBK1). It binds and deconjugates retinoic acid-inducible gene I (RIG I) and TNF receptor-associated factor 3 (TRAF3), causing their dissociation from the downstream adaptor CARDIF or TBK1 kinase. In addition to RIG I and TRAF3, HBx also interacts with CARDIF, TRIF, NEMO, TBK1, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (IKKi) and interferon regulatory factor 3 (IRF3). Our data indicate that multiple points of signaling pathways can be targeted by HBx to negatively regulate production of type I IFN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213104      PMCID: PMC4875076          DOI: 10.1007/s13238-010-0141-8

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


Supplementary material, approximately 340 KB.
  50 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

4.  The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication.

Authors:  Hong Tang; Luvsanjav Delgermaa; Feijun Huang; Naoki Oishi; Li Liu; Fang He; Liansan Zhao; Seishi Murakami
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.

Authors:  Susanne Weber; Florian Maass; Michael Schuemann; Eberhard Krause; Guntram Suske; Uta-Maria Bauer
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

6.  Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3.

Authors:  Wenwen Zeng; Ming Xu; Siqi Liu; Lijun Sun; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

7.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

8.  Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene.

Authors:  T M Whitten; A T Quets; R H Schloemer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

Authors:  Constantin S Friedman; Marie Anne O'Donnell; Diana Legarda-Addison; Aylwin Ng; Washington B Cárdenas; Jacob S Yount; Thomas M Moran; Christopher F Basler; Akihiko Komuro; Curt M Horvath; Ramnik Xavier; Adrian T Ting
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

10.  TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis.

Authors:  Tatsukata Kawagoe; Osamu Takeuchi; Yoshitsugu Takabatake; Hiroki Kato; Yoshitaka Isaka; Tohru Tsujimura; Shizuo Akira
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

View more
  46 in total

1.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 2.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

3.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

Review 4.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

5.  Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells.

Authors:  Jiradej Makjaroen; Poorichaya Somparn; Kenneth Hodge; Witthaya Poomipak; Nattiya Hirankarn; Trairak Pisitkun
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

6.  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication.

Authors:  Amanda J Hodgson; Joseph M Hyser; Victor V Keasler; Yong Cang; Betty L Slagle
Journal:  Virology       Date:  2012-02-17       Impact factor: 3.616

Review 7.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 8.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

9.  Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANK.

Authors:  Li Huang; Qinfang Liu; Lijie Zhang; Quan Zhang; Liang Hu; Changyao Li; Shengnan Wang; Jiangnan Li; Yuanfeng Zhang; Huibin Yu; Yan Wang; Zhaohua Zhong; Tao Xiong; Xueshan Xia; Xiaojun Wang; Li Yu; Guohua Deng; Xuehui Cai; Shangjin Cui; Changjiang Weng
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

10.  Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3.

Authors:  Shuai Wang; Kezhen Wang; Jie Li; Chunfu Zheng
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.